Plain-English translation of NCT07368933 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the SirPlux Duo™, a special balloon catheter coated with two medications designed to open blocked arteries in the heart. The balloon is used during a procedure to push open narrowed vessels and help restore blood flow. Researchers want to see if this treatment is safe and works well for people with chest pain or other signs of heart disease.
Blocked heart arteries can come back after treatment, and some vessels are too small for traditional stents. This medication is designed to reduce the chance of vessels closing up again and may work better in smaller arteries where other options are limited.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will undergo a heart catheterization procedure where doctors use the special SirPlux Duo balloon catheter to open your blocked artery. The procedure is performed by an interventional cardiologist in a hospital setting, similar to standard heart procedures but using this new catheter. You will need to attend follow-up visits to allow doctors to monitor your heart health and the results of the treatment.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Spain